Renal Cell Cancer Update
Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 1:14:59
- Mais informações
Informações:
Sinopse
Dr Joyce O’Shaughnessy from Sarah Cannon Research Institute in Dallas, Texas, summarizes risk factors and targeted therapy options for patients with HR-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/HRPosmBC24).
